eHealth, Inc.
Business
eHealth, Inc. is a private health insurance marketplace and agency providing omnichannel consumer engagement, education, and enrollment solutions for Medicare, individual, family, and small business health insurance plans. The company operates a technology-enabled platform allowing consumers to shop and enroll through self-service online, licensed benefit advisors, or hybrid methods, offering thousands of plans from multiple insurance carriers. eHealth derives revenue primarily from health insurance carrier commissions and other compensation rather than consumer fees, with Medicare representing the substantial majority of revenue.
Summary from 10-K filed 2026-02-26
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Total revenue | 554 | 532 | 453 | 405 | 538 | |
| Marketing and advertising | 181 | 193 | 173 | 195 | 271 | |
| Customer care and enrollment | 163 | 163 | 150 | 141 | 179 | |
| Technology and content | 52 | 54 | 59 | 79 | 84 | |
| General and administrative | 90 | 90 | 99 | 72 | 76 | |
| Impairment, restructuring and other charges | 2 | 9 | 0 | 20 | 51 | |
| Total operating costs and expenses | 488 | 509 | 482 | 508 | 664 | |
| Income from operations | 66 | 24 | −29 | −103 | −126 | |
| Interest expense | −11 | −11 | −11 | — | — | |
| Other income, net | 3 | 7 | 9 | 4 | 2 | |
| Income before income taxes | 59 | 19 | −31 | −106 | −125 | |
| Provision for income taxes | 19 | 9 | −2 | −18 | −21 | |
| Net income | 40 | 10 | −28 | −89 | −104 | |
| Preferred stock dividends | −24 | −22 | −21 | −19 | −12 | |
| Change in preferred stock redemption value | −27 | −23 | −17 | −11 | −6 | |
| Net loss attributable to common stockholders | −10 | −35 | −67 | −119 | −123 | |
| Basic (in dollars per share) | −0.34 | −1.19 | −2.37 | −4.36 | −4.59 | |
| Diluted (in dollars per share) | −0.34 | −1.19 | −2.37 | −4.36 | −4.59 | |
| Basic (in shares) | 30 | 29 | 28 | 27 | 27 | |
| Diluted (in shares) | 30 | 29 | 28 | 27 | 27 | |
| Unrealized holding gain (loss) on available for sale debt securities, net of tax | −16,000 | 55,000 | 10,000 | −29,000 | −49,000 | |
| Foreign currency translation adjustments | 188,000 | −207,000 | −19,000 | −434,000 | 89,000 | |
| Comprehensive income | 40 | 10 | −28 | −89 | −104 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 74 | 39 | 116 | 144 | 82 | |
| Short-term marketable securities | 3 | 43 | 6 | 0 | 41 | |
| Accounts receivable | 8 | 17 | 4 | 3 | 6 | |
| Contract assets commissions receivable current | 236 | 242 | 245 | 243 | 255 | |
| Prepaid expenses and other current assets | 13 | 13 | 12 | 11 | 24 | |
| Total current assets | 334 | 354 | 382 | 401 | 408 | |
| Contract assets commissions receivable non-current | 887 | 758 | 674 | 642 | 653 | |
| Property and equipment, net | 5 | 4 | 5 | 6 | 12 | |
| Operating lease right-of-use assets | 8 | 12 | 23 | 27 | 37 | |
| Restricted cash | 3 | 3 | 3 | 3 | 3 | |
| Other assets | 25 | 24 | 27 | 35 | 36 | |
| Total assets | 1,262 | 1,155 | 1,113 | 1,113 | 1,149 | |
| Accounts payable | 28 | 23 | 7 | 7 | 14 | |
| Accrued compensation and benefits | 41 | 44 | 41 | 21 | 16 | |
| Accrued marketing expenses | 16 | 17 | 20 | 24 | 36 | |
| Lease liabilities current | 7 | 8 | 7 | 6 | 6 | |
| Other current liabilities | 6 | 4 | 3 | 3 | 3 | |
| Total current liabilities | 99 | 96 | 79 | 61 | 75 | |
| Long-term debt | 113 | 68 | 68 | 66 | 0 | |
| Deferred income taxes non-current | 57 | 39 | 30 | 32 | 51 | |
| Lease liabilities non-current | 14 | 21 | 28 | 34 | 36 | |
| Other non-current liabilities | 6 | 5 | 5 | 5 | 5 | |
| Total liabilities | 289 | 229 | 209 | 198 | 167 | |
| Commitments and contingencies (Note 8) | — | — | — | — | — | |
| Convertible preferred stock, par value $0.001 per share; 2,250 issued and outstanding as of December 31, 2025 and 2024; redemption value of $$416,340 and $392,440 as of December 31, 2025 and 2024, respectively | 382 | 338 | 298 | 263 | 233 | |
| Preferred stock, par value $0.001 per share, other than convertible preferred stock; 7,750 authorized; none issued and outstanding as of December 31, 2025 and 2024 | 0 | 0 | 0 | 0 | 0 | |
| Common stock, par value $0.001 per share; 100,000 authorized; 44,797 and 43,225 issued as of December 31, 2025 and 2024, respectively; 30,994 and 29,846 outstanding as of December 31, 2025 and 2024, respectively | 44,000 | 43,000 | 41,000 | 40,000 | 39,000 | |
| Additional paid-in capital | 761 | 773 | 799 | 777 | 756 | |
| Treasury stock, at cost: 13,803 and 13,379 shares as of December 31, 2025 and 2024, respectively | −200 | −200 | −200 | −200 | −200 | |
| Retained earnings | 30 | 15 | 7 | 74 | 193 | |
| Accumulated other comprehensive loss | −62,000 | −234,000 | −82,000 | −73,000 | 390,000 | |
| Total stockholders equity | 592 | 588 | 606 | 651 | 750 | |
| Total liabilities, convertible preferred stock and stockholders equity | 1,262 | 1,155 | 1,113 | 1,113 | 1,149 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Depreciation and amortization | 2 | 2 | 3 | 4 | 5 | |
| Amortization of internally developed software | 12 | 14 | 17 | 17 | 13 | |
| Stock-based compensation expense | 15 | 20 | 23 | 20 | 33 | |
| Deferred income taxes | 18 | 9 | −3 | −18 | −22 | |
| Loss on debt extinguishment | 1 | 0 | — | — | — | |
| Impairment charges | 900,000 | 8 | 0 | 12 | 46 | |
| Other non-cash items | 247,000 | 429,000 | 701,000 | 2 | 1 | |
| Accounts receivable | 9 | −13 | −1 | 3 | −4 | |
| Contract assets commissions receivable | −123 | −82 | −34 | 24 | −116 | |
| Prepaid expenses and other assets | −5 | −4 | −2 | 13 | −8 | |
| Accounts payable | 5 | 16 | 487,000 | −7 | −23 | |
| Accrued compensation and benefits | −3 | 3 | 20 | 4 | −4 | |
| Accrued marketing expenses | −430,000 | −4 | −3 | −13 | 19 | |
| Deferred revenue | 966,000 | 1 | 1 | 175,000 | 20,000 | |
| Accrued expenses and other liabilities | 1 | 261,000 | −1 | −436,000 | 187,000 | |
| Net cash used in operating activities | −25 | −18 | −7 | −27 | −163 | |
| Capitalized internal-use software and website development costs | −13 | −11 | −9 | −15 | −17 | |
| Purchases of property and equipment and other assets | −2 | −2 | −2 | −214,000 | −4 | |
| Purchases of marketable securities | −74 | −97 | −55 | −8 | −103 | |
| Proceeds from redemption and maturities of marketable securities | 115 | 61 | 49 | 50 | 111 | |
| Net cash provided by (used in) investing activities | 25 | −48 | −16 | 26 | −13 | |
| Repayment of term loan credit facility | −71 | 0 | — | — | 0 | |
| Proceeds from revolving credit facility, net of costs | 122 | 0 | — | — | — | |
| Payments of deferred financing costs | −9 | −1 | — | — | — | |
| Net proceeds from exercise of common stock options and employee stock purchases | 404,000 | 354,000 | 677,000 | 2 | 9 | |
| Repurchase of shares to satisfy employee tax withholding obligations | −2 | −3 | −3 | −3 | −9 | |
| Principal payments in connection with leases | 0 | −4,000 | −38,000 | −136,000 | −150,000 | |
| Payments of preferred stock dividends | −6 | −6 | −4 | 0 | 0 | |
| Net cash provided by (used in) financing activities | 34 | −10 | −6 | 64 | 213 | |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | 153,000 | −64,000 | −19,000 | −355,000 | 64,000 | |
| Net increase (decrease) in cash, cash equivalents and restricted cash | 35 | −77 | −29 | 62 | 38 | |
| Cash paid for interest | 9 | 9 | 9 | 5 | 0 |
Filings
Material Events
Insiders
Institutional Holders
Frequently asked questions
What is eHealth, Inc.'s CIK number?
eHealth, Inc.'s SEC CIK number is 0001333493 (1333493). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find eHealth, Inc.'s SEC filings?
All of eHealth, Inc.'s EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.
When did eHealth, Inc. last report earnings?
eHealth, Inc. (EHTH) most recently filed an earnings 8-K with the SEC on May 6, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0001333493-26-000025). This is eHealth, Inc.'s most recent earnings filing of record — not a forecast of its next earnings date.
What is eHealth, Inc.'s most recent earnings 8-K?
eHealth, Inc.'s latest earnings 8-K (Item 2.02) was filed May 6, 2026 under accession 0001333493-26-000025. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.
View eHealth, Inc.'s latest earnings 8-K →
Look up any company's CIK number →